Oppenheimer & Co. Inc. Has $1.01 Million Holdings in Quintiles Transitional Holdings Inc. (Q)

Oppenheimer & Co. Inc. raised its stake in shares of Quintiles Transitional Holdings Inc. (NYSE:Q) by 0.7% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 11,315 shares of the medical research company’s stock after acquiring an additional 84 shares during the period. Oppenheimer & Co. Inc.’s holdings in Quintiles Transitional Holdings were worth $1,013,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of Q. Shell Asset Management Co. increased its position in Quintiles Transitional Holdings by 1.0% during the 1st quarter. Shell Asset Management Co. now owns 8,769 shares of the medical research company’s stock worth $706,000 after purchasing an additional 83 shares during the period. Bbva Compass Bancshares Inc. increased its position in Quintiles Transitional Holdings by 4.2% during the 2nd quarter. Bbva Compass Bancshares Inc. now owns 2,204 shares of the medical research company’s stock worth $197,000 after purchasing an additional 88 shares during the period. Pacer Advisors Inc. increased its position in Quintiles Transitional Holdings by 3.2% during the 1st quarter. Pacer Advisors Inc. now owns 3,738 shares of the medical research company’s stock worth $301,000 after purchasing an additional 116 shares during the period. American Century Companies Inc. increased its position in Quintiles Transitional Holdings by 1.1% during the 1st quarter. American Century Companies Inc. now owns 11,719 shares of the medical research company’s stock worth $944,000 after purchasing an additional 128 shares during the period. Finally, Cutter & CO Brokerage Inc. increased its position in Quintiles Transitional Holdings by 4.2% during the 2nd quarter. Cutter & CO Brokerage Inc. now owns 3,805 shares of the medical research company’s stock worth $341,000 after purchasing an additional 152 shares during the period. 91.36% of the stock is owned by hedge funds and other institutional investors.

In other Quintiles Transitional Holdings news, insider Ari Bousbib sold 92,160 shares of Quintiles Transitional Holdings stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $90.35, for a total value of $8,326,656.00. Following the transaction, the insider now owns 1,082,919 shares in the company, valued at $97,841,731.65. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Kevin C. Knightly sold 20,000 shares of Quintiles Transitional Holdings stock in a transaction that occurred on Wednesday, August 9th. The stock was sold at an average price of $90.28, for a total transaction of $1,805,600.00. Following the completion of the transaction, the insider now owns 46,826 shares in the company, valued at approximately $4,227,451.28. The disclosure for this sale can be found here. In the last three months, insiders have sold 6,363,847 shares of company stock worth $618,573,696. 6.40% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: “Oppenheimer & Co. Inc. Has $1.01 Million Holdings in Quintiles Transitional Holdings Inc. (Q)” was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The original version of this article can be accessed at https://sportsperspectives.com/2017/09/10/oppenheimer-co-inc-has-1-01-million-holdings-in-quintiles-transitional-holdings-inc-q.html.

Q has been the topic of several recent analyst reports. BidaskClub cut Quintiles Transitional Holdings from a “strong-buy” rating to a “buy” rating in a research report on Friday, August 11th. Zacks Investment Research upgraded Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and set a $101.00 target price on the stock in a research report on Thursday, July 27th. Barclays PLC set a $100.00 target price on Quintiles Transitional Holdings and gave the stock a “buy” rating in a research report on Friday, August 4th. Jefferies Group LLC boosted their target price on Quintiles Transitional Holdings from $78.00 to $81.00 and gave the stock a “hold” rating in a research report on Monday, May 15th. Finally, Stifel Nicolaus reiterated a “hold” rating and set a $92.00 target price (up previously from $87.00) on shares of Quintiles Transitional Holdings in a research report on Friday, August 4th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $90.25.

Shares of Quintiles Transitional Holdings Inc. (Q) opened at 97.00 on Friday. The company has a 50 day moving average price of $92.86 and a 200-day moving average price of $85.81. The firm has a market cap of $21.00 billion, a PE ratio of 281.16 and a beta of 0.63. Quintiles Transitional Holdings Inc. has a 12-month low of $70.10 and a 12-month high of $99.95.

Quintiles Transitional Holdings (NYSE:Q) last announced its earnings results on Thursday, August 3rd. The medical research company reported $1.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.04. Quintiles Transitional Holdings had a return on equity of 14.23% and a net margin of 0.82%. The firm had revenue of $1.97 billion for the quarter, compared to analysts’ expectations of $1.96 billion. During the same quarter in the previous year, the company earned $0.93 earnings per share. The firm’s quarterly revenue was up 68.7% compared to the same quarter last year. Analysts expect that Quintiles Transitional Holdings Inc. will post $4.58 EPS for the current year.

Quintiles Transitional Holdings declared that its board has initiated a stock buyback program on Wednesday, May 24th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the medical research company to reacquire up to 5.4% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s board believes its stock is undervalued.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Want to see what other hedge funds are holding Q? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quintiles Transitional Holdings Inc. (NYSE:Q).

Institutional Ownership by Quarter for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply